Literature DB >> 2180893

Clindamycin in malaria treatment.

P G Kremsner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2180893     DOI： 10.1093/jac/25.1.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

Review 1.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 2.  Resistant Malaria : Current Concepts and Therapeutic Strategies.

Authors:  S P Kalra; N Naithani; S R Mehta; Rajat Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Fosmidomycin for the treatment of malaria.

Authors:  Jochen Wiesner; Steffen Borrmann; Hassan Jomaa
Journal:  Parasitol Res       Date:  2002-11-30       Impact factor: 2.289

4.  Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.

Authors:  Maud Henry; Sébastien Briolant; Agnès Zettor; Stéphane Pelleau; Meili Baragatti; Eric Baret; Joel Mosnier; Rémy Amalvict; Thierry Fusai; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

5.  High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic.

Authors:  W Metzger; B Mordmüller; W Graninger; U Bienzle; P G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.

Authors:  Jochen Wiesner; Dajana Henschker; David B Hutchinson; Ewald Beck; Hassan Jomaa
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 7.  Treating severe malaria in pregnancy: a review of the evidence.

Authors:  Stephanie D Kovacs; Marcus J Rijken; Andy Stergachis
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 8.  The genomic architecture of antimalarial drug resistance.

Authors:  Annie N Cowell; Elizabeth A Winzeler
Journal:  Brief Funct Genomics       Date:  2019-09-24       Impact factor: 4.241

9.  Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.

Authors:  Ronnatrai Ruangweerayut; Sornchai Looareesuwan; David Hutchinson; Anurak Chauemung; Vick Banmairuroi; Kesara Na-Bangchang
Journal:  Malar J       Date:  2008-10-31       Impact factor: 2.979

10.  Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.

Authors:  Charles O Obonyo; Elizabeth A Juma; Vincent O Were; Bernhards R Ogutu
Journal:  Malar J       Date:  2022-02-02       Impact factor: 2.979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.